1.
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Glob...
by Abd-Allah, Foad
The Lancet (British edition), 2017, Vol.390 (10100), p.1211-1259
2.
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016:...
by Abate, Kalkidan Hassen
The Lancet (British edition), 2017, Vol.390 (10100), p.1260-1344
3.
Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled...
by Arits, Aimée HMM, Dr
The lancet oncology, 2013, Vol.14 (7), p.647-654
4.
Cancer incidence among firefighters: 45 years of follow-up in five Nordic countries
by Pukkala, Eero
Occupational and environmental medicine (London, England), 2014, Vol.71 (6), p.398-404
5.
High body mass index and cancer risk—a Mendelian randomisation study
by Benn, Marianne
European journal of epidemiology, 2016, Vol.31 (9), p.879-892
6.
Merkel Cell Carcinoma Therapeutic Update
by Cassler, Nicole M
Current Treatment Options in Oncology, 2016, Vol.17 (7), p.36-36
7.
Coffee, tea and caffeine intake and the risk of non-melanoma skin cancer: a review of the literature and meta-analysis
by Caini, Saverio
European Journal of Nutrition, 2016, Vol.56 (1), p.1-12
8.
An update on local and systemic therapies for nonmelanoma skin cancer
by Elleson, Kelly M
Expert review of anticancer therapy, 2022, Vol.22 (5), p.479-489
9.
Cutaneous Complications of Targeted Melanoma Therapy
by de Golian, Emily
Current Treatment Options in Oncology, 2016, Vol.17 (11), p.57
10.
Case-control study of smoking and non-melanoma skin cancer
by Rollison, Dana E
Cancer causes & control, 2012, Vol.23 (2), p.245-254
11.
Treatment of NRAS-Mutant Melanoma
by Johnson, Douglas B
Current treatment options in oncology, 2015, Vol.16 (4), p.15-15
12.
Risk of non-melanoma skin cancer for rheumatoid arthritis patients receiving TNF antagonist: a systematic review and meta-analysis
by Wang, Jiang-lin
Clinical rheumatology, 2019, Vol.39 (3), p.769-778
13.
Obesity and the incidence of skin cancer in US Caucasians
by Pothiawala, Salma
Cancer causes & control, 2012, Vol.23 (5), p.717-726
14.
Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990–2015: a novel analysis from the Global Bu...
by Abbas, Kaja M
The Lancet (British edition), 2017, Vol.390 (10091), p.231-266
15.
Chemopreventive effects of curcumin on chemically induced mouse skin carcinogenesis in BK5.insulin-like growth factor-1 transgenic mice
by Kim, Hyoseon
In vitro cellular & developmental biology. Animal, 2014, Vol.50 (9), p.883-892
16.
Management of Non-Melanoma Skin Cancer in Immunocompromised Solid Organ Transplant Recipients
by Bangash, Haider K
Current treatment options in oncology, 2012, Vol.13 (3), p.354-376
17.
Trends in incidence and survival analysis in non-melanoma skin cancer from 1994 to 2012 in Girona, Spain: A population-based study
by Rubió-Casadevall, J
Cancer epidemiology, 2016, Vol.45, p.6-10
18.
Long-noncoding RNAs in basal cell carcinoma
by Sand, Michael
Tumor biology, 2016, Vol.37 (8), p.10595-10608
19.
Management of High-Risk Squamous Cell Carcinoma of the Skin
by Fu, Teresa
Current Treatment Options in Oncology, 2016, Vol.17 (7), p.34-34
20.
Hat, shade, long sleeves, or sunscreen? Rethinking US sun protection messages based on their relative effectiveness
by Linos, Eleni
Cancer causes & control, 2011, Vol.22 (7), p.1067-1071
